Baxter International Inc. $BAX Shares Bought by Dodge & Cox

Key Points

• Dodge & Cox increased its stake in Baxter International by 2.1%, owning over 51 million shares valued at approximately $1.76 billion as of the latest SEC filing.
• Baxter International reported a quarterly earnings per share of $0.59, missing the consensus estimate by $0.01, along with a revenue of $2.81 billion, slightly below analysts' expectations.
• The company recently announced a quarterly dividend of $0.17 per share, with a payout ratio currently at -226.67%.

Dodge & Cox raised its position in Baxter International Inc. (NYSE:BAX - Free Report) by 2.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,458,925 shares of the medical instruments supplier's stock after acquiring an additional 1,081,631 shares during the period. Dodge & Cox owned approximately 10.03% of Baxter International worth $1,761,439,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. SVB Wealth LLC acquired a new stake in shares of Baxter International during the first quarter worth $138,000. Allstate Corp lifted its stake in shares of Baxter International by 10.5% during the first quarter. Allstate Corp now owns 17,041 shares of the medical instruments supplier's stock worth $583,000 after buying an additional 1,621 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of Baxter International by 1.1% during the first quarter. Ameriprise Financial Inc. now owns 7,540,942 shares of the medical instruments supplier's stock worth $258,140,000 after buying an additional 83,973 shares during the period. BI Asset Management Fondsmaeglerselskab A S lifted its stake in shares of Baxter International by 41.7% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 20,063 shares of the medical instruments supplier's stock worth $687,000 after buying an additional 5,907 shares during the period. Finally, Horizon Investments LLC lifted its stake in shares of Baxter International by 5.0% during the first quarter. Horizon Investments LLC now owns 7,438 shares of the medical instruments supplier's stock worth $255,000 after buying an additional 351 shares during the period. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on BAX. Wells Fargo & Company lowered their price objective on shares of Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Citigroup decreased their target price on shares of Baxter International from $34.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, July 9th. Stifel Nicolaus restated a "hold" rating and set a $25.00 target price (down from $36.00) on shares of Baxter International in a research report on Monday, August 4th. Barclays decreased their target price on shares of Baxter International from $41.00 to $36.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Morgan Stanley decreased their target price on shares of Baxter International from $28.00 to $27.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Baxter International presently has a consensus rating of "Hold" and an average price target of $30.11.

Baxter International Stock Up 2.7%

BAX opened at $24.4950 on Friday. Baxter International Inc. has a fifty-two week low of $21.33 and a fifty-two week high of $40.49. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.49 and a current ratio of 2.30. The company has a fifty day moving average of $27.46 and a two-hundred day moving average of $30.17. The stock has a market capitalization of $12.58 billion, a price-to-earnings ratio of -81.65, a PEG ratio of 0.78 and a beta of 0.59.

Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The firm had revenue of $2.81 billion during the quarter, compared to analysts' expectations of $2.82 billion. During the same period in the previous year, the firm posted $0.68 EPS. The firm's quarterly revenue was up 4.3% on a year-over-year basis. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. On average, research analysts expect that Baxter International Inc. will post 2.48 earnings per share for the current year.

Baxter International Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.8%. Baxter International's payout ratio is currently -226.67%.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.